Summary:
- Kodiak Sciences is scheduled to present topline clinical trial results for their investigational drug, tarcocimab tedromer, during the EURETINA Congress.
- The presentation focuses on the GLEAM and GLIMMER Phase 3 studies, which evaluate the efficacy and safety of this biopolymer-based therapy in treating diabetic macular edema.